Company intelligence / Profile preview

Marvao Medical

Ownership: Private
Employees: ~6
Development stage: Commercial

Overview

Marvao Medical developed the NexSite haemodialysis catheter, an implantable medical device designed to reduce the risk of catheter-related infections by promoting a biological seal at the exit site. The company now also provides product development services for early-stage medical device companies. Clinical results are not detailed in public sources.

Therapeutic areas: NephrologyInfectious Diseases
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

2 assets

NexSite HD

Commercial

Indications: Hemodialysis

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborates with OEMs and US contract distributors for product development and distribution support; no major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on Marvao Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marvao Medical.

Explore the full profile